We are live on ! Find out more
DP

Dearborn Partners Portfolio holdings

AUM $1.85B
1-Year Est. Return 6.59%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+6.59%
3 Year Est. Return
+44.33%
5 Year Est. Return
+68.05%
10 Year Est. Return
+241.41%
AUM
$1.35B
AUM Growth
+$68M
Cap. Flow
+$28.8M
Cap. Flow %
2.13%
Top 10 Hldgs %
25.11%
Holding
175
New
8
Increased
67
Reduced
51
Closed
6

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$13.4M
2
HD icon
Home Depot
HD
+$13.1M
3
APD icon
Air Products & Chemicals
APD
+$5.69M
4
FTS icon
Fortis
FTS
+$4.33M
5
GBCI icon
Glacier Bancorp
GBCI
+$2.46M

Top Sells

Rank Stock Value
1
VAL
Valspar
VAL
+$27.4M
2
GWW icon
W.W. Grainger
GWW
+$10.3M
3
WTRG icon
Essential Utilities
WTRG
+$4.15M
4
QCOM icon
Qualcomm
QCOM
+$2.02M
5
VFC icon
VF Corp
VFC
+$286K

Sector Composition

Rank Sector Weight
1 Healthcare 16.64%
2 Industrials 15.29%
3 Technology 14.26%
4 Financials 10.3%
5 Consumer Staples 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBSH icon
26
Commerce Bancshares
CBSH
$8.55B
$21.2M 1.57%
578,645
+27,996
+5% +$999K
WEC icon
27
WEC Energy
WEC
$35.8B
$20.9M 1.54%
340,217
+16,369
+5% +$1.01M
SJM icon
28
J.M. Smucker
SJM
$12.9B
$20.7M 1.53%
174,748
+7,010
+4% +$886K
TRV icon
29
Travelers Companies
TRV
$78.7B
$20.2M 1.49%
159,598
+3,470
+2% +$427K
AIZ icon
30
Assurant
AIZ
$13.9B
$19.9M 1.47%
191,553
+4,242
+2% +$422K
SBUX icon
31
Starbucks
SBUX
$120B
$19.3M 1.42%
330,584
+24,807
+8% +$1.5M
CVS icon
32
CVS Health
CVS
$134B
$18.5M 1.37%
229,770
+5,253
+2% +$415K
VFC icon
33
VF Corp
VFC
$5.73B
$18.3M 1.35%
338,055
-5,535
-2% -$286K
FTS icon
34
Fortis
FTS
$29.3B
$18.3M 1.35%
520,799
+130,098
+33% +$4.33M
UNP icon
35
Union Pacific
UNP
$173B
$18.3M 1.35%
168,060
+2,232
+1% +$243K
GBCI icon
36
Glacier Bancorp
GBCI
$6.39B
$18.1M 1.34%
494,531
+72,019
+17% +$2.46M
MRK icon
37
Merck
MRK
$321B
$18.1M 1.34%
295,810
+6,425
+2% +$391K
XOM icon
38
ExxonMobil
XOM
$635B
$18M 1.33%
222,644
+2,376
+1% +$194K
BR icon
39
Broadridge
BR
$17.8B
$17.2M 1.27%
227,247
+7,378
+3% +$533K
ACN icon
40
Accenture
ACN
$99.6B
$15.8M 1.17%
128,028
+3,520
+3% +$429K
IFF icon
41
International Flavors & Fragrances
IFF
$20.1B
$15.4M 1.14%
114,063
+3,684
+3% +$500K
GILD icon
42
Gilead Sciences
GILD
$161B
$15.4M 1.14%
217,227
+4,485
+2% +$298K
BCR
43
DELISTED
CR Bard Inc.
BCR
$15.1M 1.12%
47,877
-55
-0.1% -$16.3K
NEE icon
44
NextEra Energy
NEE
$183B
$14.7M 1.08%
418,348
-6,112
-1% -$209K
SYK icon
45
Stryker
SYK
$123B
$14.4M 1.06%
103,614
+97,740
+1,664% +$13.4M
EFX icon
46
Equifax
EFX
$20.3B
$14M 1.03%
101,846
+3,248
+3% +$446K
LEG icon
47
Leggett & Platt
LEG
$1.36B
$13.5M 1%
257,297
+8,139
+3% +$425K
WBA
48
DELISTED
Walgreens Boots Alliance
WBA
$13.5M 1%
172,446
+15,848
+10% +$1.3M
HD icon
49
Home Depot
HD
$329B
$13.1M 0.97%
+85,532
New +$13.1M
GD icon
50
General Dynamics
GD
$102B
$13.1M 0.97%
65,930
+300
+0.5% +$58.8K

Similar funds

Dearborn Partners's Q2 2017 Portfolio in Review

As of Q2 2017, Dearborn Partners held 175 positions worth $1.35B, up 5.3% from $1.29B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Dearborn Partners's Q2 2017 filing shows 8 new, 67 increased, 51 reduced and 6 closed positions. Its largest new stake was Home Depot: 85,532 shares worth $13.1M. The largest sale was Valspar, an estimated $27.4M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

  • Dearborn Partners's largest Q2 2017 buy was Home Depot: 85,532 shares worth $13.1M.
  • Dearborn Partners added most to Stryker in Q2 2017, an estimated $13.4M increase.
  • Dearborn Partners's biggest Q2 2017 reduction was Qualcomm, cutting an estimated $2.02M.
  • Dearborn Partners fully exited Valspar in Q2 2017, selling an estimated $27.4M.
  • Dearborn Partners's ten largest holdings make up 25% of its $1.35B portfolio in Q2 2017.
  • Dearborn Partners opened 8 new positions and closed 6 in Q2 2017.
  • Dearborn Partners's portfolio value rose 5.3% quarter-over-quarter to $1.35B.

Based on Dearborn Partners's 13F filing for Q2 2017, filed 9 Aug 2017.